Conflict of interest in clinical practice guideline development: A systematic review

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Norris, Susan L ^a   Holmer, Haley K ^a   Ogden, Lauren A ^a   Burda, Brittany U ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONFLICT OF INTEREST; CONSULTATION; DIAGNOSTIC TEST; DOCTOR PATIENT RELATION; DRUG INDUSTRY; FINANCE; HEALTH INSURANCE; HUMAN; INTERPERSONAL COMMUNICATION; ORGANIZATION; PATIENT REFERRAL; PRACTICE GUIDELINE; SYSTEMATIC REVIEW; REVIEW;

CONFLICT OF INTEREST; DRUG INDUSTRY; PRACTICE GUIDELINES AS TOPIC;

EID: 80054782091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025153     Document Type: Article

References (50)

1. Evidence-Based Medicine Working Group (1992) Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268: 2420-2425.
2. Institute of Medicine (2008) Knowing what works in health care: A roadmap for the nation Washington, DC The National Academies Press.
3. Institute of Medicine (2011) Clinical Practice Guidelines We Can Trust; Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, eds. Washington, D.C. THe National Academies Press.
4. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J, (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318: 527-530.
5. Davis DA, Taylor-Vaisey A, (1997) Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Canadian Medical Association Journal 157: 408-416.
6. Lugtenberg M, Burgers JS, Westert GP, (2009) Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Quality & Safety in Health Care 18: 385-392.
7. van der Sanden WJM, Mettes DG, Plasschaert AJM, Grol RPTM, Mulder J, et al. (2005) Effectiveness of clinical practice guideline implementation on lower third molar management in improving clinical decision-making: a randomized controlled trial. European Journal of Oral Sciences 113: 349-354.
8. Thompson DF, (1993) Understanding financial conflicts of interest. New England Journal of Medicine 329: 573-576.
9. Laupacis A, (2006) On bias and transparency in the development of influential recommendations. Canadian Medical Association Journal 174: 335-336.
10. Bekelman JE, Li Y, Gross CP, (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289: 454-465.
11. Lexchin J, Bero LA, Djulbegovic B, Clark O, (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170.
12. Stelfox HT, Chua G, O'Rourke K, Detsky AS, (1998) Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine 338: 101-106.
13. Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO, et al. (2008) Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology 71: 57-63.
14. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. (2007) A national survey of physician-industry relationships. New England Journal of Medicine 356: 1742-1750.
15. Choudhry NK, Stelfox HT, Detsky AS, (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287: 612-617.
16. Chren MM, Landefeld CS, (1994) Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271: 684-689.
17. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL, (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290: 921-928.
18. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, et al. (2010) The vexing problem of guidelines and conflict of interest: a potential solution. Annals of Internal Medicine 152: 738-741.
19. Levinsky NG, (2002) Nonfinancial conflicts of interest in research. New England Journal of Medicine 347: 759-761.
20. Alpert JS, Shine KI, Adams RJ, Antman EM, Kavey RE, et al. (2004) Task force 1: The ACCF and AHA codes of conduct in human subjects research. Journal of the American College of Cardiology 44: 1724-1728.
21. Deeks J, Dinnes J, D'Amico R, Sowden A, Sakarovitch C, et al. (2003) Evaluating non-randomised intervention studies Health Technology Assessment (Winchester, England) 7.
22. Taylor R, Giles J, (2005) Cash interests taint drug advice. Nature 437: 1070-1071.
23. Coyne DW, (2007) Influence of industry on renal guideline development. Clinical Journal of The American Society of Nephrology: CJASN 2: 3-7.
24. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J, (2009) Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. Psychotherapy & Psychosomatics 78: 228-232.
25. Johnson L, Stricker RB, (2009) Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. Journal of Medical Ethics 35: 283-288.
26. Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L, (2006) Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy & Psychosomatics 75: 154-160.
27. Cosgrove L, Bursztajn HJ, Krimsky S, (2009) Developing unbiased diagnostic and treatment guidelines in psychiatry. New England Journal of Medicine 360: 2035-2036.
28. Papanikolaou GN, Baltogianni MS, Contopoulos-Ioannidis DG, Haidich AB, Giannakakis IA, et al. (2001) Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Medical Research Methodology 1: 3.
29. Buchan HA, Currie KC, Lourey EJ, Duggan GR, (2010) Australian clinical practice guidelines-a national study. Medical Journal of Australia 192: 490-494.
30. Hietanen P, (2009) Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer? Annals of Oncology 20: 1749-1751; author reply 1751-1742.
31. Drazen JM, Van Der Weyden MB, Sahni P, Rosenberg J, Marusic A, et al. (2009) Uniform format for disclosure of competing interests in ICMJE journals. Lancet 374: 1395-1396.
32. Kuehn BM, (2010) Payments to physicians, medical schools to be illuminated under new reform law. JAMA 303: 2237-2238.
33. Campbell EG, (2010) Public disclosure of conflicts of interest: moving the policy debate forward. Archives of Internal Medicine 170: 667.
34. Licurse A, Barber E, Joffe S, Gross C, (2010) The impact of disclosing financial ties in research and clinical care: a systematic review. Archives of Internal Medicine 170: 675-682.
35. Insel TR, (2010) Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution? JAMA 303: 1192-1193.
36. Campbell EG, Zinner DE, (2010) Disclosing Industry Relationships - Toward an Improved Federal Research Policy. New England Journal of Medicine July 14: 1-3.
37. Council of Medical Specialty Societies (2010. Accessed at http://www.cmss.org/uploadedFiles/Site/CMSS_Policies/CMSS%20Code%20for%20Interactions%20with%20Companies%204-19-10.pdf on 20 July 2010) Code for Interactions with Companies.
38. Association of American Medical Colleges (2010) (2010. Accessed at https://services.aamc.org/publications/showfile.cfm?file=version163.pdf&prd_id=303&prv_id=375&pdf_id=163 on 20 July 2010) In the Interest of Patients: Recommendations for Physician Financial Relationships and Clinical Decision Making.
39. International Committee of Medical Journal Editors (2010. Accessed at http://www.icmje.org/sample_disclosure.pdf on 20 July 2010) Uniform Disclosure Form for Potential Conflicts of Interest.
40. Institute of Medicine (2009) Conflict of Interest in Medical Research, Education, and Practice; Lo B, Field MJ, eds. Washington, D.C. The National Academies Press.
41. Institute of Medicine (2010) Accessed at http://www.iom.edu/Activities/Quality/ClinicPracGuide.aspx on 20 July 2010) Standards for Developing Trustworthy Clinical Practice Guidelines.
42. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, et al. (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 64: 383-394.
43. Lederer ED, (2007) Development of clinical practice guidelines: are we defining the issues too narrowly? Clinical Journal of The American Society of Nephrology: CJASN 2: 207.
44. Lo B, Field MJ, (2009) Conflict of Interest in Medical Research, Education, and Practice. pp. 1-414.
45. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr, et al. (2009) Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301: 831-841.
46. Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M, et al. (2009) Accuracy of conflict-of-interest disclosures reported by physicians. New England Journal of Medicine 361: 1466-1474.
47. Chaudhry S, Schroter S, Smith R, Morris J, Chaudhry S, et al. (2002) Does declaration of competing interests affect readers' perceptions? A randomised trial. BMJ 325: 1391-1392.
48. Schroter S, Morris J, Chaudhry S, Smith R, Barratt H, et al. (2004) Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial. BMJ 328: 742-743.
49. Krimsky S, Rothenberg LS, (1998) Financial interest and its disclosure in scientific publications. JAMA 280: 225-226.
50. Silverman GK, Loewenstein GF, Anderson BL, Ubel PA, Zinberg S, et al. (2010) Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians. Journal of Medical Ethics 36: 265-270.